{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Neurodegenerative diseases (NGDs)", "genetic", "natural product", "neurological dysfunction", "neuroprotective.", "patient", "plants"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38265386", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "22"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "22"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0118715249273015231225091339"], "ArticleDate": [], "Journal": {"ISSN": "1875-6166", "JournalIssue": {"Volume": "24", "Issue": "2", "PubDate": {"Year": "2024"}}, "Title": "Central nervous system agents in medicinal chemistry", "ISOAbbreviation": "Cent Nerv Syst Agents Med Chem"}, "ArticleTitle": "Exploring the Therapeutic Potential of Phytoconstituents for Addressing Neurodegenerative Disorders.", "Pagination": {"StartPage": "129", "EndPage": "144", "MedlinePgn": "129-144"}, "Abstract": {"AbstractText": ["Neurodegenerative disorder is a serious condition that is caused by abnormal or no neurological function. Neurodegenerative disease is a major growing cause of mortality and morbidity worldwide, especially in the elderly. After World War \u2161, eugenics term was exterminated from medicines. Neurodegenerative disease is a genetically inherited disease. Lifestyle changes, environmental factors, and genetic modification, together or alone, are involved in the occurrence of this disorder. The major examples of neurodegenerative disorders are Alzheimer's and Parkinson's disease, in which apoptosis and necrosis are the two major death pathways for neurons. It has been determined from various studies that the etiology of the neurodegenerative disease involves the role of oxidative stress and anti-oxidant defence system, which are prime factors associated with the activation of signal transduction pathway that is responsible for the formation of synuclein in the brain and manifestation of toxic reactions in the form of functional abnormality, which ultimately leads to the dysfunction of neuronal pathway or cell. There has not been much success in the discovery of effective therapy to treat neurodegenerative diseases because the main cause of abnormal functioning or death of neurons is not well known. However, the use of natural products that are derived from plants has effective therapeutic potential against neurodegenerative disease. The natural compounds with medicinal properties to prevent neurological dysfunction are curcumin, wolfberry, ginseng, and Withania somnifera. The selection and use of natural compounds are based on their strong anti-inflammatory and anti-oxidant properties against neurodegenerative disease. Herbal products have active constituents that play an important role in the prevention of communication errors between neurons and neurotransmitters and their respective receptors in the brain, which influence their function. Considering this, natural products have great potential against neurodegenerative diseases. This article reviews the natural compounds used to treat neurodegenerative diseases and their mechanisms of action."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India."}], "LastName": "Kamboj", "ForeName": "Sweta", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India."}], "LastName": "Sharma", "ForeName": "Prerna", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India."}], "LastName": "Kamboj", "ForeName": "Rohit", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India."}], "LastName": "Kamboj", "ForeName": "Shikha", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India."}], "LastName": "Hariom"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India."}], "LastName": "Girija"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamuna Nagar, India."}], "LastName": "Guarve", "ForeName": "Kumar", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gandhi Memorial National College, Ambala, India."}], "LastName": "Dutt", "ForeName": "Rohit", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "MM College of Pharmacy, MM (Deemed to be University), Mullana, Ambala, India."}], "LastName": "Verma", "ForeName": "Inderjeet", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Pharmacy Graduate of Technology, Sydney, Australia."}], "LastName": "Dua", "ForeName": "Kamal", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Chandigarh, Punjab, India."}], "LastName": "Rani", "ForeName": "Nidhi", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Cent Nerv Syst Agents Med Chem", "NlmUniqueID": "101269163", "ISSNLinking": "1871-5249"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["therapeutic use", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["pharmacology", "therapeutic use", "chemistry"], "DescriptorName": "Biological Products"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Checkoway H.; Lundin J.L.; Kelada S.N.; Application of biomarkers to disease: Neurodegenerative disease 2011,22(5),407-420"}, {"Citation": "Amin M.M.; Handbook of research on critical examinations of neurodegenerative disorder. National research centre 2019,1-22"}, {"Citation": "Kovacs G.G.; Current concept of neurodegenerative disease. Institute of neurology, medical university of Vienna, Austria. EMJ Neuronal 2014,1,78-86"}, {"Citation": "Srivastava P.; Yadav R.S.; Efficacy of natural compounds in neurodegenerative disorders. Adv Neurobiol 2016,12,107-123", "ArticleIdList": ["10.1007/978-3-319-28383-8_7", "27651251"]}, {"Citation": "Di Paolo M.; Papi L.; Gori F.; Turillazzi E.; Natural products in neurodegenerative disease: A great promise but an ethical challenge. Int J Mol Sci 2019,20(20),5170", "ArticleIdList": ["10.3390/ijms20205170", "31635296"]}, {"Citation": "Devranis P.; Vassilopoulou E.; Aivaliotis M.; Chourdakis M.; Tsolaki M.; Natural product against neurodegenerative disease progression. ICONSD 2022,2(1A),21"}, {"Citation": "What is Alzheimer\u2019s disease: Cause, diagnosis, treatment. Available from: https://www.nia.nih.gov/health/what-alzheimers-disease"}, {"Citation": "Parkinson's disease: What it is, causes, symptoms and treatment Available from: https://my.clevelandclinic.org/health/diseases/8525-parkinsons-disease-an-overview"}, {"Citation": "Parkinson\u2019s disease: Causes, symptoms, and treatments. Available from: http://www.nia.nih.goc/gov/health/parkinson-disease2022"}, {"Citation": "Wijesekera L.C.; Leigh P.N.; Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009,4(4),3"}, {"Citation": "Rowland L.P.; Shneider N.A.; Amyotrophic lateral sclerosis. N Engl J Med 2001,344(22),1688-1700", "ArticleIdList": ["10.1056/NEJM200105313442207", "11386269"]}, {"Citation": "Kauffman J.S.; Zinovyeva A.; Yagi K.; Makabe K.W.; Raff R.A.; Neural expression of the Huntington\u2019s disease gene as a chordate evolutionary novelty. J Exp Zool B Mol Dev Evol 2003,297(1),57-64"}, {"Citation": "Aarsland D.; Epidemiology and pathophysiology of dementia-related psychosis. J Clin Psychiatry 2020,81(5)"}, {"Citation": "Kolb S.J.; Kissel J.T.; Spinal muscular atrophy. Neurol Clin 2015,33(4),831-846", "ArticleIdList": ["10.1016/j.ncl.2015.07.004", "26515624"]}, {"Citation": "Fanciulli A.; Stankovic I.; Krismer F.; Seppi K.; Levin J.; Wenning G.K.; Multiple system atrophy. Int Rev Neurobiol 2019,149,137-192", "ArticleIdList": ["10.1016/bs.irn.2019.10.004", "31779811"]}, {"Citation": "Sullivan R.; Yau W.Y.; O\u2019Connor E.; Houlden H.; Spinocerebellar ataxia: An update. J Neurol 2019,266(2),533-544", "ArticleIdList": ["10.1007/s00415-018-9076-4", "30284037"]}, {"Citation": "Garc\u00eda Morales L.; Mustelier B\u00e9cquer R.G.; P\u00e9rez Joglar L.; Zald\u00edvar Vaillant T.; Sandhoff disease in the elderly: A case study. Amyotroph Lateral Scler Frontotemporal Degener 2022,23(1-2),137-138", "ArticleIdList": ["10.1080/21678421.2021.1892146", "33650927"]}, {"Citation": "Hayashi T.; Mori N.; Subacute combined degeneration of the spinal cord. Intern Med 2022,10", "ArticleIdList": ["35945006"]}, {"Citation": "Lakhan S.; what are neurodegenerative disease? Toketemu ohwovoriole. 2022"}, {"Citation": "Kovacs G.G.; Budka H.; Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. Clin Neuropathol 2010,29(9),271-288", "ArticleIdList": ["10.5414/NPP29271", "20860890"]}, {"Citation": "Nijholt D.A.; De Kimpe L.; Elfrink H.L.; Hoozemans J.J.; Scheper W.; Removing protein aggregates: The role of proteolysis in neurodegeneration. Curr Med Chem 2011,18(16),2459-2476", "ArticleIdList": ["10.2174/092986711795843236", "21568912"]}, {"Citation": "Murugaiyah V.; Mattson M.P.; Neurohormetic phytochemicals: An evolutionary\u2013bioenergetic perspective. Neurochem Int 2015,89,271-280", "ArticleIdList": ["10.1016/j.neuint.2015.03.009", "25861940"]}, {"Citation": "Ross C.A.; Poirier M.A.; Protein aggregation and neurodegenerative disease. Nat Med 2004,10,S10-S17", "ArticleIdList": ["10.1038/nm1066"]}, {"Citation": "Leng F.; Edison P.; Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nat Rev Neurol 2021,17(3),157-172", "ArticleIdList": ["10.1038/s41582-020-00435-y", "33318676"]}, {"Citation": "Nissanka N.; Moraes C.T.; Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease. FEBS Lett 2018,592(5),728-742", "ArticleIdList": ["10.1002/1873-3468.12956", "29281123"]}, {"Citation": "Federico A.; Cardaioli E.; Da Pozzo P.; Formichi P.; Gallus G.N.; Radi E.; Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012,322(1-2),254-262", "ArticleIdList": ["10.1016/j.jns.2012.05.030", "22669122"]}, {"Citation": "Armstrong, Richard What causes neurodegenerative disease? Folia neuropathological 2020,58(2),93-112", "ArticleIdList": ["10.5114/fn.2020.96707"]}, {"Citation": "Tansey M.G.; Wallings R.L.; Houser M.C.; Herrick M.K.; Keating C.E.; Joers V.; Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 2022,22(11),657-673", "ArticleIdList": ["10.1038/s41577-022-00684-6", "35246670"]}, {"Citation": "Carrell R.W.; Lomas D.A.; Conformational disease. Lancet 1997,350(9071),134-138", "ArticleIdList": ["10.1016/S0140-6736(97)02073-4", "9228977"]}, {"Citation": "Mbongwe B.; Nkatogang M.; Tapera R.; Erick P.; Tumoyagae T.; Molefe T.; Letsholo B.; Self-reported respiratory symptoms among students exposed to second hand smoke (SHS) in academic instituions in Gaborone: Implications for public health interventions. Pub Health Tox 2022,2(4),1-8", "ArticleIdList": ["10.18332/pht/157596"]}, {"Citation": "Ibara M.; Early sign of neurodegenerative disease Available from: www.healthline.com/health/brain-disorders#types2016,22"}, {"Citation": "Dawsan R.; The short list of the neurodegenerative disease\u2019s symptoms. Most Common Symptoms of Neurodegenerative Disease 2021"}, {"Citation": "Doudet D.J.; Neurodegenerative disease. Mol Imaging Biol 2007,9(4),159-160", "ArticleIdList": ["10.1007/s11307-007-0099-y", "17447108"]}, {"Citation": "Levenson R.W.; Sturm V.E.; Haase C.M.; Emotional and behavioral symptoms in neurodegenerative disease: A model for studying the neural bases of psychopathology. Annu Rev Clin Psychol 2014,10(1),581-606", "ArticleIdList": ["10.1146/annurev-clinpsy-032813-153653", "24437433"]}, {"Citation": "Lovergne L.; Ghosh D.; Schuck R.; Polyzos A.A.; Chen A.D.; Martin M.C.; Barnard E.S.; Brown J.B.; McMurray C.T.; An infrared spectral biomarker accurately predicts neurodegenerative disease class in the absence of overt symptoms. Sci Rep 2021,11(1),15598", "ArticleIdList": ["10.1038/s41598-021-93686-8"]}, {"Citation": "Westfall S.; Lomis N.; Kahouli I.; Dia S.Y.; Singh S.P.; Prakash S.; Microbiome, probiotics and neurodegenerative diseases: Deciphering the gut brain axis. Cell Mol Life Sci 2017,74(20),3769-3787", "ArticleIdList": ["10.1007/s00018-017-2550-9", "28643167"]}, {"Citation": "Heemels M.T.; Neurodegenerative diseases. Nature 2016,539(7628),179", "ArticleIdList": ["10.1038/539179a", "27830810"]}, {"Citation": "Berman T.; Bayati A.; What are neurodegenerative diseases and how do they affect the brain? Front Young Minds 2018,6,70", "ArticleIdList": ["10.3389/frym.2018.00070"]}, {"Citation": "Balthazar M.L.; Pereira F.R.; Lopes T.M.; Silva E.L.; Coan A.C.; Neuropsychiatric symptoms in Alzheimer\u2019s disease are related to functional connectivity alterations in the salience network. Hum Brain Mapp 2013", "ArticleIdList": ["23418130"]}, {"Citation": "Apostolova L.G.; Cummings J.L.; Neuropsychiatric manifestations in mild cognitive impairment: A systematic review of the literature. Dement Geriatr Cogn Disord 2008,25(2),115-126", "ArticleIdList": ["10.1159/000112509", "18087152"]}, {"Citation": "Aron A.R.; Friston K.J.; The neural basis of inhibition in cognitive control. Neuroscientist 2007,13(3),214-228", "ArticleIdList": ["10.1177/1073858407299288", "17519365"]}, {"Citation": "Glenner G.G.; Wong C.W.; Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984,120(3),885-890", "ArticleIdList": ["10.1016/S0006-291X(84)80190-4", "6375662"]}, {"Citation": "Sheikh N.; Top Risk Factors for Neurodegenerative Disease 2021"}, {"Citation": "Emard J.F.; Thouez J.P.; Gauvreau D.; Neurodegenerative diseases and risk factors: A literature review. Soc Sci Med 1995,40(6),847-858", "ArticleIdList": ["10.1016/0277-9536(94)00138-J", "7747220"]}, {"Citation": "Khachaturian A.S.; Khachaturian Z.S.; Military risk factors for Alzheimer\u2019s dementia and neurodegenerative disease. Alzheimers Dement 2014,10(3S)(Suppl.),S90-S91", "ArticleIdList": ["10.1016/j.jalz.2014.05.1085", "24924677"]}, {"Citation": "Hou Y.; Dan X.; Babbar M.; Wei Y.; Hasselbalch S.G.; Croteau D.L.; Bohr V.A.; Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 2019,15(10),565-581", "ArticleIdList": ["10.1038/s41582-019-0244-7", "31501588"]}, {"Citation": "Rose M.R.; Adaptation, aging, and genomic information. Aging 2009,1(5),444-450", "ArticleIdList": ["10.18632/aging.100053", "20157529"]}, {"Citation": "Dean D.C.; Jerskey B.A.; Chen K.; Protas H.; Thiyyagura P.; Roontiva A.; O\u2019Muircheartaigh J.; Dirks H.; Waskiewicz N.; Lehman K.; Siniard A.L.; Turk M.N.; Hua X.; Madsen S.K.; Thompson P.M.; Fleisher A.S.; Huentelman M.J.; Deoni S.C.L.; Reiman E.M.; Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: A cross-sectional imaging study. JAMA Neurol 2014,71(1),11-22", "ArticleIdList": ["10.1001/jamaneurol.2013.4544", "24276092"]}, {"Citation": "Maynard S.; Schurman S.H.; Harboe C.; de Souza-Pinto N.C.; Bohr V.A.; Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2008,30(1),2-10", "ArticleIdList": ["10.1093/carcin/bgn250", "18978338"]}, {"Citation": "Tell G.; Demple B.; Base excision DNA repair and cancer. Oncotarget 2015,6(2),584-585", "ArticleIdList": ["10.18632/oncotarget.2705", "25655644"]}, {"Citation": "Mohd Sairazi N.S.; Sirajudeen K.N.S.; Natural products and their bioactive compounds: Neuroprotective potentials against neurodegenerative disease. Evid Based Complement Alternat Med 2020,2020,1-30", "ArticleIdList": ["10.1155/2020/6565396"]}, {"Citation": "Pohl F.; Kong T.L.P.; The potential use of plant natural products and plant extracts with antioxidant properties for the prevention/ treatment of neurodegenerative diseases: In vitro, in vivo and clinical trials. Molecules 2018,23(12),3283"}, {"Citation": "Hu S.; Maiti P.; Ma Q.; Zuo X.; Jones M.R.; Cole G.M.; Frautschy S.A.; Clinical development of curcumin in neurodegenerative disease. Expert Rev Neurother 2015,15(6),629-637", "ArticleIdList": ["10.1586/14737175.2015.1044981", "26035622"]}, {"Citation": "Dar N.J.; Ahmad M.; Neurodegenerative disease and withania somifera (L.). An update 2020,\u2022,112769"}, {"Citation": "Ho Shan Y.; 2020, 112769. [55] Ho, Shan Y.; Y.M., Shan Neuroprotective effects of polysaccharides from wolfberry: The fruit of Lcium barbarum, against Homocysteine- induced toxicity in rat cortical neurons. 2010"}, {"Citation": "Limbocker R.; Errico S.; Barbut D.; Knowles T.P.J.; Vendruscolo M.; Chiti F.; Zasloff M.; Squalamine and trodusquemine: Two natural products for neurodegenerative diseases, from physical chemistry to the clinic. Nat Prod Rep 2022,39(4),742-753", "ArticleIdList": ["10.1039/D1NP00042J", "34698757"]}, {"Citation": "Christen Y.; Ginkgo biloba and neurodegenerative disorders. Front Biosci 2004,9(1-3),3091-3104", "ArticleIdList": ["10.2741/1462", "15353340"]}, {"Citation": "Ong W.Y.; Farooqui T.; Koh H.L.; Farooqui A.A.; Ling E.A.; Protective effects of ginseng on neurological disorders. Front Aging Neurosci 2015,7,129", "ArticleIdList": ["10.3389/fnagi.2015.00129", "26236231"]}, {"Citation": "Hadrich F.; Chamkha M.; Sayadi S.; Protective effect of olive leaves phenolic compounds against neurodegenerative disorders: Promising alternative for Alzheimer\u2019s and Parkinson\u2019s disease modulation. Food Chem Toxicol 2022,159", "ArticleIdList": ["10.1016/j.fct.2021.112752"]}, {"Citation": "Giacoppo S.; Galuppo M.; Lombardo G.E.; Ulaszewska M.M.; Mattivi F.; Bramanti P.; Mazzon E.; Navarra M.; Neuroprotective effects of a polyphenolic white grape juice extract in a mouse model of experimental autoimmune encephalomyelitis. Fitoterapia 2015,103,171-186", "ArticleIdList": ["10.1016/j.fitote.2015.04.003", "25863350"]}, {"Citation": "Zhang N.; Dou D.; Ran X.; Kang T.; Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone. RSC Advances 2018,8(5),2280-2292", "ArticleIdList": ["10.1039/C7RA10906G", "35541453"]}, {"Citation": "Shabgah A.G.; Suksatan W.; Achmad M.H.; Bokov D.O.; Abdelbasset W.K.; Ezzatifar F.; Hemmati S.; Mohammadi H.; Soleimani D.; Jadidi-Niaragh F.; Ahmadi M.; Navashenaq J.G.; Arctigenin, an anti-tumor agent; A cutting-edge topic and up-to-the-minute approach in cancer treatment. Eur J Pharmacol 2021,909,174419", "ArticleIdList": ["10.1016/j.ejphar.2021.174419", "34391770"]}, {"Citation": "Christensen K.; Doblhammer G.; Rau R.; Vaupel J.W.; Ageing populations: The challenges ahead. Lancet 2009,374(9696),1196-1208", "ArticleIdList": ["10.1016/S0140-6736(09)61460-4", "19801098"]}, {"Citation": "Mbongwe B.; Nkatogang M.; Tapera R.; Erick P.; Tumoyagae T.; Molefe T.; Letsholo B.; Self-reported respiratory symptoms among students exposed to second hand smoke (SHS) in academic instituions in Gaborone: Implications for public health interventions. Public Health and Toxicology 2022,2(4),1-8", "ArticleIdList": ["10.18332/pht/157596"]}, {"Citation": "Kaur M.; Olive oil: Sources, preparation, and uses. Available from: http://www.yourarticlelibrary.com/biology//lipids/olive-oil-sources-preparation-and-uses/49569"}, {"Citation": "Dorsey E.R.; Constantinescu R.; Thompson J.P.; Biglan K.M.; Holloway R.G.; Kieburtz K.; Marshall F.J.; Ravina B.M.; Schifitto G.; Siderowf A.; Tanner C.M.; Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007,68(5),384-386", "ArticleIdList": ["10.1212/01.wnl.0000247740.47667.03", "17082464"]}, {"Citation": "Friedli M.J.; Inestrosa N.C.; Huperzine A and its neuroprotective molecular signalling in Alzheimer\u2019s disease. Nat Prod Chem Mol 2021,26(21),6531", "ArticleIdList": ["10.3390/molecules26216531", "34770940"]}, {"Citation": "Lim M.K.; Lee S.; Kim J.Y.; Jeong J.; Han E.H.; Lee S.H.; Ryu J.H.; Lee J.; Neuroprotective and anti-neuroinflammatory effects of ethanolic extract from leaves and stems of Aster glehni. J Funct Foods 2021,79,104400", "ArticleIdList": ["10.1016/j.jff.2021.104400"]}, {"Citation": "Sayad-Fathi S.; Zaminy A.; Babaei P.; Yousefbeyk F.; Azizi N.; Nasiri E.; The methanolic extract of Cinnamomum zeylanicum bark improves formaldehyde-induced neurotoxicity through reduction of phospho-tau (Thr231), inflammation, and apoptosis. EXCLI J 2020,19,671-686", "ArticleIdList": ["32536837"]}, {"Citation": "Shah S.A.; Lee H.Y.; Bressan R.A.; Yun D.J.; Kim M.O.; Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain. Cell Death Dis 2014,5(1),e1026-e1026", "ArticleIdList": ["10.1038/cddis.2013.538", "24481440"]}, {"Citation": "Lee W.; Fujihashi A.; Govindarajulu M.; Ramesh S.; Deruiter J.; Majrashi M.; Role of mushrooms in neurodegenerative disease. Med Mushrooms 2019,223-249", "ArticleIdList": ["10.1007/978-981-13-6382-5_8"]}, {"Citation": "van der Eijk Y.; Porter G.; Human rights and ethical considerations for a tobacco-free generation. Tob Control 2015,24(3),238-242", "ArticleIdList": ["10.1136/tobaccocontrol-2013-051125", "24114564"]}, {"Citation": "Ma Q.L.; Zuo X.; Yang F.; Ubeda O.J.; Gant D.J.; Alaverdyan M.; Teng E.; Hu S.; Chen P.P.; Maiti P.; Teter B.; Cole G.M.; Frautschy S.A.; Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J Biol Chem 2013,288(6),4056-4065", "ArticleIdList": ["10.1074/jbc.M112.393751", "23264626"]}, {"Citation": "Tucker J.S.; Rodriguez A.; Dunbar M.S.; Pedersen E.R.; Davis J.P.; Shih R.A.; D\u2019Amico E.J.; Cannabis and tobacco use and co-use: Trajectories and correlates from early adolescence to emerging adulthood. Drug Alcohol Depend 2019,204,107499", "ArticleIdList": ["10.1016/j.drugalcdep.2019.06.004", "31479864"]}, {"Citation": "Cabrera O.A.; Gostin L.O.; Human rights and the framework convention on tobacco control: Mutually reinforcing systems. Int J Law Context 2011,7(3),285-303", "ArticleIdList": ["10.1017/S1744552311000139"]}, {"Citation": "Chen Y.F.; Wang Y.W.; Huang W.S.; Lee M.M.; Wood W.G.; Leung Y.M.; Tsai H.Y.; Trans-cinnamaldehyde: An essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of iNOS, COX-2 expression and NF\u03ba-B signaling pathway. Neuromolecular Med 2016,18(3),322-333", "ArticleIdList": ["10.1007/s12017-016-8395-9", "27087648"]}, {"Citation": "Calcul L.; Zhang B.; Jinwal U.K.; Dickey C.A.; Baker B.J.; Natural products as a rich source of tau-targeting drugs for Alzheimer\u2019s disease. Future Med Chem 2012,4(13),1751-1761", "ArticleIdList": ["10.4155/fmc.12.124", "22924511"]}, {"Citation": "Pyo J.H.; Jeong Y.K.; Yeo S.; Lee J.H.; Jeong M.Y.; Kim S.H.; Choi Y.G.; Lim S.; Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury. Biol Pharm Bull 2013,36(12),1928-1935", "ArticleIdList": ["10.1248/bpb.b13-00537", "24292051"]}, {"Citation": "Xiong Z.; Hongmei Z.; Lu S.; Yu L.; Curcumin mediates presenilin-1 activity to reduce \u03b2-amyloid production in a model of Alzheimer\u2019s disease. Pharmacol Rep 2011,63(5),1101-1108", "ArticleIdList": ["10.1016/S1734-1140(11)70629-6", "22180352"]}, {"Citation": "Tapia-Rojas C.; Burgos P.V.; Inestrosa N.C.; Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid-\u03b2 (A\u03b2) 42 peptides. J Neurochem 2016,139(6),1175-1191", "ArticleIdList": ["10.1111/jnc.13873", "27778356"]}, {"Citation": "Leone P.; Comoletti D.; Taylor P.; Bourne Y.; Marchot P.; Structure\u2013function relationships of the \u03b1/\u03b2-hydrolase fold domain of neuroligin: A comparison with acetylcholinesterase. Chem Biol Interact 2010,187(1-3),49-55", "ArticleIdList": ["10.1016/j.cbi.2010.01.030", "20100470"]}, {"Citation": "Carvajal F.J.; Inestrosa N.C.; Interactions of AChE with A? Aggregates in Alzheimer?s brain: Therapeutic relevance of IDN 5706. Front Mol Neurosci 2011,4,19", "ArticleIdList": ["10.3389/fnmol.2011.00019", "21949501"]}, {"Citation": "Thakur P.; Nehru B.; Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson\u2019s disease. Neuroscience 2013,231,420-431", "ArticleIdList": ["10.1016/j.neuroscience.2012.11.006", "23159314"]}, {"Citation": "Brunden K.R.; Ballatore C.; Crowe A.; Smith A.B.; Lee V.M.Y.; Trojanowski J.Q.; Tau-directed drug discovery for Alzheimer\u2019s disease and related tauopathies: A focus on tau assembly inhibitors. Exp Neurol 2010,223(2),304-310", "ArticleIdList": ["10.1016/j.expneurol.2009.08.031", "19744482"]}, {"Citation": "Luheshi L.M.; Dobson C.M.; Bridging the gap: From protein misfolding to protein misfolding diseases. FEBS Lett 2009,583(16),2581-2586", "ArticleIdList": ["10.1016/j.febslet.2009.06.030", "19545568"]}, {"Citation": "Abramov A.Y.; Berezhnov A.V.; Fedotova E.I.; Zinchenko V.P.; Dolgacheva L.P.; Interaction of misfolded proteins and mitochondria in neurodegenerative disorders. Biochem Soc Trans 2017,45(4),1025-1033", "ArticleIdList": ["10.1042/BST20170024", "28733489"]}, {"Citation": "Zempel H.; Mandelkow E.; Lost after translation: Missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci 2014,37(12),721-732", "ArticleIdList": ["10.1016/j.tins.2014.08.004", "25223701"]}, {"Citation": "Jankovic J.; Parkinson\u2019s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008,79(4),368-376", "ArticleIdList": ["10.1136/jnnp.2007.131045", "18344392"]}, {"Citation": "McNaught K.S.P.; Olanow C.W.; Halliwell B.; Isacson O.; Jenner P.; Failure of the ubiquitin\u2013proteasome system in Parkinson\u2019s disease. Nat Rev Neurosci 2001,2(8),589-594", "ArticleIdList": ["10.1038/35086067", "11484002"]}, {"Citation": "Okamoto M.; Gray J.D.; Larson C.S.; Kazim S.F.; Soya H.; McEwen B.S.; Pereira A.C.; Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer\u2019s disease. Transl Psychiatry 2018,8(1),153", "ArticleIdList": ["10.1038/s41398-018-0201-z", "30108205"]}, {"Citation": "Bogie J.; Hoeks C.; Schepers M.; Tiane A.; Cuypers A.; Leijten F.; Chintapakorn Y.; Suttiyut T.; Pornpakakul S.; Struik D.; Kerksiek A.; Liu H.B.; Hellings N.; Martinez-Martinez P.; Jonker J.W.; Dewachter I.; Sijbrands E.; Walter J.; Hendriks J.; Groen A.; Staels B.; L\u00fctjohann D.; Vanmierlo T.; Mulder M.; Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer\u2019s disease mouse model. Sci Rep 2019,9(1),4908", "ArticleIdList": ["10.1038/s41598-019-41399-4", "30894635"]}, {"Citation": "Patil P.; Thakur A.; Sharma A.; Flora S.J.S.; Natural products and their derivatives as multifunctional ligands against Alzheimer\u2019s disease. Drug Dev Res 2020,81(2),165-183", "ArticleIdList": ["10.1002/ddr.21587", "31820476"]}, {"Citation": "Ahmed T.; Gilani A.H.; Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer\u2019s disease. Pharmacol Biochem Behav 2009,91(4),554-559", "ArticleIdList": ["10.1016/j.pbb.2008.09.010"]}, {"Citation": "Cheignon C.; Tomas M.; Bonnefont-Rousselot D.; Faller P.; Hureau C.; Collin F.; Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 2018,14,450-464", "ArticleIdList": ["10.1016/j.redox.2017.10.014", "29080524"]}, {"Citation": "K\u00fcpeli E.; Ko\u015far, M.; Ye\u015filada, E.; Ba\u015fer, K.H.C.; Ba\u015fer, C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 2002,72(6),645-657", "ArticleIdList": ["10.1016/S0024-3205(02)02200-2", "12467905"]}, {"Citation": "Xu J.; Wang H.; Ding K.; Zhang L.; Wang C.; Li T.; Wei W.; Lu X.; Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2\u2013ARE pathway. Free Radic Biol Med 2014,71,186-195", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.03.009", "24642087"]}, {"Citation": "Yanagisawa D.; Taguchi H.; Morikawa S.; Kato T.; Hirao K.; Shirai N.; Tooyama I.; Novel curcumin derivatives as potent inhibitors of amyloid \u03b2 aggregation. Biochem Biophys Rep 2015,4,357-368", "ArticleIdList": ["10.1016/j.bbrep.2015.10.009", "29124225"]}, {"Citation": "Zhuo J.M.; Portugal G.; Kruger W.; Wang H.; Gould T.; Pratico D.; Diet-induced hyperhomocysteinemia increases amyloid-\u03b2 formation and deposition in a mouse model of Alzheimer\u2019s disease. Curr Alzheimer Res 2010,7(2),140-149", "ArticleIdList": ["10.2174/156720510790691326", "19939226"]}, {"Citation": "Schaafsma J.D.; Balash Y.; Gurevich T.; Bartels A.L.; Hausdorff J.M.; Giladi N.; Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson\u2019s disease. Eur J Neurol 2003,10(4),391-398", "ArticleIdList": ["10.1046/j.1468-1331.2003.00611.x", "12823491"]}, {"Citation": "Conradsson D.; Nero H.; L\u00f6fgren N.; Hagstr\u00f6mer M.; Franz\u00e9n E.; Monitoring training activity during gait-related balance exercise in individuals with Parkinson\u2019s disease: A proof-of-concept-study. BMC Neurol 2017,17(1),19", "ArticleIdList": ["10.1186/s12883-017-0804-7", "28143463"]}, {"Citation": "Natbony L.R.; Zimmer A.; Ivanco L.S.; Studenski S.A.; Jain S.; Perceptions of a videogame-based dance exercise program among individuals with Parkinson\u2019s disease. Games Health J 2013,2(4),235-239", "ArticleIdList": ["10.1089/g4h.2013.0011", "24761325"]}, {"Citation": "Lee N.Y.; Lee D.K.; Song H.S.; Effect of virtual reality dance exercise on the balance, activities of daily living, and depressive disorder status of Parkinson\u2019s disease patients. J Phys Ther Sci 2015,27(1),145-147", "ArticleIdList": ["10.1589/jpts.27.145", "25642060"]}, {"Citation": "Schoene D.; Wu S.M.S.; Mikolaizak A.S.; Menant J.C.; Smith S.T.; Delbaere K.; Lord S.R.; Discriminative ability and predictive validity of the timed up and go test in identifying older people who fall: systematic review and meta-analysis. J Am Geriatr Soc 2013,61(2),202-208", "ArticleIdList": ["10.1111/jgs.12106", "23350947"]}]}], "History": [{"Year": "2023", "Month": "7", "Day": "19"}, {"Year": "2023", "Month": "10", "Day": "3"}, {"Year": "2023", "Month": "11", "Day": "20"}, {"Year": "2024", "Month": "7", "Day": "22", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "24", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "24", "Hour": "10", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38265386", "10.2174/0118715249273015231225091339", "CNSAMC-EPUB-137706"]}}]}